COVID-19: Pill Being Touted As Potential Cure For Virus Could Be Coming COVID-19: Pill Being Touted As Potential Cure For Virus Could Be Coming
Covid-19: Pill Being Touted As Potential Cure For Virus Could Be Coming An anti-viral pill that's being touted as a potential cure for COVID-19 could be ready later this year, according to a brand-new report. PF-07321332, an antiviral drug being developed by Pfizer, is designed to attack the “spine” of the COVID-19 virus to prevent it from replicating in the nose, throat, and lungs, according to the Telegraph. Trials involving volunteers from age 18 to 60 are now underway at Pfizer facilities in both the United States and Europe, according to the report. Pizer's director of medicinal chemistry, Dafydd Owen, said the pill was developed from scratch, the Te…
COVID-19: Walk-In Vaccine Clinic To Open In Westchester; Here's Latest Rundown By Community COVID-19: Walk-In Vaccine Clinic To Open In Westchester; Here's Latest Rundown By Community
Covid-19: Walk-In Vaccine Clinic To Open In Westchester; Here's Latest Rundown By Community A walk-in COVID-19 vaccine clinic is being opened in Westchester as the county continues combating the spread of the virus. During his bi-weekly COVID-19 briefing on Monday, April 26, Westchester County Executive announced that beginning at 9 a.m. on Friday, April 30, the Department of Health was opening a first-dose Moderna vaccine clinic 134 Court St. in White Plains that will accept walk-ins. Hospitalizations for COVID-19 continue to drop as Westchester continues ramping up its vaccination program, a sign that Latimer called "encouraging."  "It appears the vaccination numbers are i…
COVID-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women COVID-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women
Covid-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women Results of the largest study conducted by the Centers for Disease Control and Prevention (CDC) on the use of two-dose COVID-19 vaccines by pregnant women have been released. The new study, published this week in the New England Journal of Medicine, found that out of more than 35,000 people who were pregnant or soon to become pregnant, there is no evidence to suggest that the Pfizer or Moderna COVID vaccines pose risk during pregnancy. Little data has been released on the Johnson & Johnson one-dose vaccine, which had run into production issues before distribution was paused following rep…
COVID-19: Here's Number Of Fully Vaccinated Westchester Residents; Latest Cases By Community COVID-19: Here's Number Of Fully Vaccinated Westchester Residents; Latest Cases By Community
Covid-19: Here's Number Of Fully Vaccinated Westchester Residents; Latest Cases By Community Westchester continues ramping up its COVID-19 vaccination program as a third of all residents are fully vaccinated, with nearly half receiving at least one dose of the vaccine, according to County Executive George Latimer. During his latest COVID-19 briefing on Thursday, April 22, Latimer said that 324,216 Westchester residents - representing approximately a third of the population - have completed the vaccination series, with hundreds of thousands more receiving at least one shot of the Pfizer or Moderna vaccine and waiting to finish the process.  The county has suspended the use…
COVID-19: Here's Number Of Americans Who've Become Infected Despite Being Vaccinated, CDC Says COVID-19: Here's Number Of Americans Who've Become Infected Despite Being Vaccinated, CDC Says
Covid-19: Here's Number Of Americans Who've Become Infected Despite Being Vaccinated, CDC Says The Centers for Disease Control & Prevention (CDC) has released the first data on so-called "breakthrough" COVID-19 cases, meaning those who have become infected despite being fully vaccinated. So far, there have been about 5,800 such cases, the CDC told CNN.  At the time that data was collected, 77 million American adults had been fully vaccinated, meaning 99.992 percent had dodged the disease. The efficacy rates of the double-dose Pfizer and Moderna vaccines are both around 95 percent. "To date, no unexpected patterns have been identified in case demographics or vaccine ch…
COVID-19: Side Effects Are More Likely After Second Pfizer Or Moderna Dose; Here's Why COVID-19: Side Effects Are More Likely After Second Pfizer Or Moderna Dose; Here's Why
Covid-19: Side Effects Are More Likely After Second Pfizer Or Moderna Dose; Here's Why Feeling a bit sleepy, sore, and achy after getting your COVID-19 vaccine? Don't fret. Side effects are a sign that the body's immune system is responding to the dose, and that it's working, according to medical experts.  One of them, Dr.Allison Arwady, the Chicago Department of Public Health Commissioner, said younger people are more likely to experience side effects because they "have more robust immune system broadly," according to a report by NBC 5 Chicago. Women are also more likely to report side effects than men, Arwady said, noting estrogen can elevate immune response…
COVID-19: Moderna Seeks Full FDA Approval For Vaccine COVID-19: Moderna Seeks Full FDA Approval For Vaccine
Covid-19: Moderna Seeks Full FDA Approval For Vaccine With six months having passed since Moderna began clinical trials for its COVID-19 vaccine, the pharmaceutical company is seeking full approval from the Food and Drug Administration. Moderna, which currently has emergency use authorization from the FDA to distribute its vaccine, reported in its latest trial data that it has proven 90 percent effective in preventing the symptoms of COVID-19, and 95 percent effective in the most severe cases of the virus. Currently, no COVID-19 vaccine is fully approved by the FDA, but three - Moderna, Pfizer, and the currently questionable Johnson & John…
COVID-19 Combo Pack: Mixup Leads To Man Getting One Dose Each Of Moderna, Pfizer Vaccines COVID-19 Combo Pack: Mixup Leads To Man Getting One Dose Each Of Moderna, Pfizer Vaccines
Covid-19 Combo Pack: Mixup Leads To Man Getting One Dose Each Of Moderna, Pfizer Vaccines Call it a COVID-19 combo pack. A New England man is telling his story after a mixup led to him getting one dose each of the Moderna and Pfizer COVID-19 vaccines. New Hampshire resident Craig Richards quickly noticed on Tuesday, April 13 that the second dose he had just received was a Pfizer shot. His first dose had been the Moderna vaccine. "As soon as he poked me, he looked down at my card, and I think he realized he just gave me the Pfizer," Richards told ABC-TV affiliated WMUR of Manchester, New Hampshire. A supervisor at the site, the same place Richards received his first dose, …
COVID-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines COVID-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines
Covid-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines The ratio of people who have suffered from blood clots after receiving the Moderna or Pfizer COVID-19 vaccine is approximately the same as those who receive the AstraZeneca vaccine, according to a new study. Oxford University researchers found that the number of people who receive blood clots after getting vaccinated is approximately the same for all three vaccines, with four in one million people experiencing cerebral venous thrombosis (CVT) after getting the Pfizer or Moderna vaccine, compared to five in one million people for the AstraZeneca vaccine. The new study comes in the wake of A…
COVID-19: Pfizer CEO Reveals When Vaccine Booster Shot Likely Will Be Needed After Second Dose COVID-19: Pfizer CEO Reveals When Vaccine Booster Shot Likely Will Be Needed After Second Dose
Covid-19: Pfizer CEO Reveals When Vaccine Booster Shot Likely Will Be Needed After Second Dose Pfizer CEO Albert Bourla is cautioning that patients will likely need a third dose of the company’s COVID-19 vaccine within the next year to maintain the shot’s efficacy. During a recently aired interview, Bourla said that patients will “likely” need an additional dose of the vaccine within 12 months of becoming fully vaccinated with the two required doses. Bourla said that they are continuing to monitor the situation, and as more COVID-19 variants arise, the company may be forced to shift gears. “We need to see what would be the sequence, and for how often we need to do that, that remains…
COVID-19: Did You Get Now-Paused J&J Vaccine? These Are Rare Symptoms To Watch For, CDC Says COVID-19: Did You Get Now-Paused J&J Vaccine? These Are Rare Symptoms To Watch For, CDC Says
Covid-19: Did You Get Now-Paused J&J Vaccine? These Are Rare Symptoms To Watch For, CDC Says The one-dose Johnson & Johnson COVID-19 vaccine has proven efficient in getting the needles in as many Americans’ arms as possible, but some are reporting debilitating side effects after receiving their shot. Recently, some have come forward with severe symptoms after being administered the COVID-19 vaccine, prompting some health officials to issue warnings and the FDA to press pause on distributing new allocations to pharmacies and healthcare providers across the country. Earlier story - CDC, FDA Call For Pause On Johnson & Johnson Vaccine Symptoms include a severe, persisting hea…
COVID-19: Brand-New Trial Reveals Moderna Vaccine's Effectiveness After Six Months COVID-19: Brand-New Trial Reveals Moderna Vaccine's Effectiveness After Six Months
Covid-19: Brand-New Trial Reveals Moderna Vaccine's Effectiveness After Six Months The Moderna COVID-19 vaccine loses a bit of its effectiveness after six months, though not as much as originally thought, according to the latest trial conducted by the pharmaceutical company. Moderna found in its latest trial that its COVID-19 vaccine maintains at least 90 percent of its efficacy in battling the virus after six months. Related story - COVID:19: COVID-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Vaccine Recipients Researchers said the latest data evaluated 33 adults who participated in Phase 1 of Moderna’s vaccine study, which found the antibodies pers…